Formulary

All drugs recommended by a NICE technology appraisal are available within NHS Northamptonshire Intergrated Care Board (ICB) as a treatment option for the disease or condition covered, if the patient meets the clinical criteria set out in the guidance. If the clinician concludes and the patient agrees that the drug recommended by the NICE technology is the most appropriate one to use, based on a discussion of all available treatments, then that treatment can be chosen.

This Primary Care Drugs Formulary lists medicines that are preferred choice within Northamptonshire.

Please check the traffic light section on the NHS Northamptonshire ICB Primary Care Portal for listings of amber (recommended and/or initiated in secondary care), red (hospital only) and double red (prior approval required) drugs.

Gastro-intestinal system

Antacids

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB

Aluminium and magnesium containing antacids  
Co-Magaldrox
Low in sodium

Alginate-containing (Reflux only)
Peptac® Liquid 
Available as aniseed and peppermint flavour

Antispasmodics

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB

Mebeverine 135mg tablets

Ulcer Healing Drugs

Lansoprazole capsules
Unlicensed in paediatrics

Omeprazole capsules
Licensed in paediatrics
Capsules are lower in cost than tablets.
If 40mg required it is more cost effective to prescribe 2x20mg capsules

Lansoprazole orodispersible - Only for patients unable to swallow since cost is higher than capsules.
First line in children who require PPI via NG tube or have difficulty swallowing. Disperse in small amount of water and administer via NG tube or oral syringe where appropriate

Anti-motility

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB

Loperamide 2mg capsule

Laxatives

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB

Bulk-forming laxatives
Ispaghula Husk

Stimulant laxatives
Senna tablets

Osmotic laxatives
Lactulose
Macrogol compound 
Adult preparations available- Laxido® Sugar-Free or Cosmocol® brand.
Paediatric preparations available- Laxido® Paediatric Plain 6.9g or Cosmocol® paediatric 6.9g
Relaxit® Microenema

Local preparations for anal and rectal disorders

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB

Anusol® cream / ointment 
Scheriproct® ointment/suppositories

Cardiovascular system

Guidance

NICE NG136: Hypertension in adults: diagnosis and management
NICE NG106: Chronic heart failure in adults: diagnosis and management
NICE TA388: Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction
NICE TA267: Ivabradine for treating chronic heart failure
NICE TA223: Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
NICE TA355: Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
NICE TA275: Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation
NICE TA249: Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation
NICE TA256: Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
NICE TA261: Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
NICE TA287: Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism
NICE TA210: Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events
NICE NG238: Cardiovascular disease: risk assessment and reduction, including lipid modification
NICE TA694: Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia
NICE TA733: Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia
NICE TA393: Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
NICE TA394: Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
NICE TA679: Dapagliflozin for treating chronic heart failure with reduced ejection fraction
NICE TA902: Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
NICE TA773: Empagliflozin for treating chronic heart failure with reduced ejection fraction
NICE NG28: Type 2 diabetes in adults: management

Positive Inotropic drugs

Cardiac glycosides 
Digoxin 

Diuretics

Thiazides and related diuretics 
Bendroflumethiazide 2.5mg
Indapamide 2.5mg 

Loop diuretics
Furosemide

Aldosterone antagonists
Spironolactone
Eplerenone

Beta-adrenoreceptor blocking drugs 

Atenolol
Propranolol
Bisoprolol 
Carvedilol

Beta-blockers and ACE inhibitors are first line treatment for heart failure. A Beta-blocker licensed for heart failure should be used eg. Bisoprolol or Carvedilol. Dose titration is required, see below:

Heart failure (target doses of preferred beta-blockers-if tolerated)

 
Bisoprolol 10mg once a day
Carvedilol

25mg twice a day (in severe heart failure or body weight less than 85kg)

50mg twice a day (body weight over 85 kg)

Alpha-Adrenoreceptor Blockers

Doxazosin
Alpha-blockers are 4th line antihypertensive agents unless there is compelling indication for their use eg. prostatism. 
Do NOT use Doxazosin XL as it is “Double Red”

Angiotensin- converting enzyme inhibitors

Ramipril
Lisinopril
Perindopril erbumine

Angiotensin-II-receptor antagonists

Losartan
Candesartan - drug of choice in heart failure if AIIRA required

Heart failure (target doses of preferred beta-blockers-if tolerated)

 
Ramipril 5mg twice a day or 10mg once a day
Lisinopril 35mg once a day
Perindopril 4mg once a day
Candesartan 32mg once a day
Losartan 150mg once a day

Nitrates, calcium-channel blockers and potassium channel activators

Nitrates 
Glyceryl Trinitrate (Sublingual spray and tablets)
Monomil XL® or Chemydur XL®
Isosorbide mononitrate
Prescribe generically
Standard release preparations should have asymmetric dosing (eg. 8am and 2pm)

Calcium-channel blockers
Amlodipine
Verapamil
Diltiazem M/R
Prescribe by brand, preferred brands are:
Slozem® - prefered ONCE a day preparation
Viazem XL® - supply problem April 2025
Tildiem® Retard - prefered TWICE a day preparation 

Other anti-anginal drugs
Nicorandil

Peripheral vasodilators and related drugs

Naftidrofuryl oxalate
NICE TA223 - Naftidrofuryl oxalate is recommended as an option for the treatment of intermittent claudication in people with peripheral arterial disease for whom vasodilator therapy is considered appropriate after taking into account other treatment options.

Anticoagulants

Warfarin

For DOACs check traffic light classification for each indication
Apixaban
- Generic tablets are prefered twice a day DOAC
Rivaroxaban - Generic tablets are prefered twice a day DOAC
Dabigatran (generic)

Commissioning recommendations for national procurement for direct-acting oral anticoagulant(s) (DOACs)- January 2024

Antiplatelet drugs

Aspirin 75mg 
Clopidogrel 75mg
Prasugrel
Ticagrelor
Dipyridamole 200mg M/R

Lipid-regulating drugs

Statins 
Atorvastatin
Rosuvastatin tablets
Pravastatin

Ezetimibe
Ezetimibe
Do not prescribe as Ezetrol® brand as it is “Double Red”

Lipid-regulating drugs 
Bempedoic acid
Bempedoic acid and ezetimibe (Nustendi)

Other lipid modifying drugs 
Inclisiran- GREEN (Specialist Recommended)
NHS England » Funding and supply of inclisiran (Leqvio®)

SGLT2 Inhibitors for heart failure

Dapagliflozin
Empagliflozin

Respiratory system

Guidance

Asthma guidelines 12 years plus [pdf] 429KB
Northamptonshire COPD Guidelines [pdf] 207KB
Guide to inhaler dose equivalents when switching patients to formulary choice dry powder inhalers [pdf] 235KB
Inhaler Repeat Durations Guideline [pdf] 185KB
Patient decision aid on asthma inhalers and climate change 
How to use your inhaler | Asthma + Lung UK
How to use a pMDI inhaler with a spacer – single breath and hold
How to use a pMDI inhaler with a spacer – tidal breathing
Inhaled corticosteroid doses for the BTS, NICE and SIGN asthma guideline

 

Bronchodilators   

Short-acting beta2 agonists
Easyhaler Salbutamol®DPI 100 microgram per inhalation
Low carbon footprint
Salamol®(Salbutamol) CFC-free pMDI 100microgram per inhalation
Lower carbon footprint compared with generic due to lower volume propellant
Airomir®(Salbutamol) CFC-free pMDI 100microgram per inhalation
High carbon footprint, lower volume propellant
Note - Ventolin® pMDI and generic salbutamol pMDI are DOUBLE RED 
 
Long acting beta2 agonists  
Formoterol Easyhaler®DPI
Low carbon footprint
Olodaterol Soft Mist Inhaler (Striverdi Respimat®)
Low carbon footprint 
Formoterol pMDI
High carbon footprint

Antimuscarinic bronchodilators

Short Acting
Ipratropium pMDI
High carbon footprint

Long Acting
Long acting antimuscarinic antagonists (LAMA) are classified:
Green for COPD
Green SR for asthma

Tiotropium DPI
Prescribe by brand, preferred brands are:
Acopair Neumohaler®18microgram
Device plus inhalation powder capsules
Low carbon footprint
Tiogiva®18 microgram 
Device plus inhalation powder capsules or refill pack of capsules only.
Low carbon footprint

Spiriva Respimat® Soft mist inhaler - Only if unable to use dry powder inhaler.
Low carbon footprint 
Aclidinium DPI (Eklira Genuair®)
Low carbon footprint

Theophylline

Modified Release Theophylline tablet
Prescribe by brand, preferred brand is:
Uniphyllin Continus®

Compound bronchodilator preparations: LAMA + LABA

Prescribe by brand, preferred brands are:
Duaklir Genuair® DPI (340/12)  [Aclidinium bromide (LAMA) and formoterol fumarate (LABA)]
Low carbon footprint
Spiolto Respimat®DPI (2.5/2.5) [Tiotropium bromide (LAMA) and olodaterol hydrochloride (LABA)]
Low carbon footprint

Spacer devices

Provide a spacer that is compatible with the person's metered-dose inhaler.
A2A spacer®
EasyChamber®
Volumatic®
Aerochamber Plus ®

How to use a spacer: 2 techniques
Single breath and hold: How to use a pMDI inhaler with a spacer – single breath and hold
Tidal breathing/multiple breath technique: This is usually recommended if you can’t hold your breath for five seconds after using your inhaler or if you are having an asthma attack. How to use a pMDI inhaler with a spacer – tidal breathing

Corticosteroids

When switching between corticosteroid products be aware of dose inequivalence. See Inhaled corticosteroid doses for the BTS, NICE and SIGN asthma guideline and local Guide to inhaler dose equivalents when switching patients to formulary choice dry powder inhalers [pdf] 235KB 

Single component inhaled corticosteroid
Products are only licensed for use in asthma, not COPD.

Prescribe by brand, preferred brands are:
Budesonide Easyhaler®DPI
Low carbon footprint 
Soprobec®cfc-free pMDI (Beclometasone dipropionate, standard particle)
High carbon footprint

Combination (LABA/ICS) inhalers  

Dry powder inhalers 
Prescribe by brand, preferred brands are:
Fobumix Easyhaler® (Budesonide and formoterol) 
Low carbon footprint
Licensed for:
Asthma from 6 years (fixed dose)
MART and AIR from 12 years
COPD in adults
WockAIR®(Budesonide and formoterol)
Low carbon footprint.

Fostair 200/6 NEXThaler®(Formoterol and fine-particle beclomethasone) - Only for severe asthma 
Low carbon footprint
Licensed for asthma only in adults.

Pressurised metered dose inhalers (Use with spacer)
Prescribe by brand, preferred brands are:
Bibecfo®(fine-particle beclomethasone and formoterol)
High carbon footprint.
Luforbec®(fine-particle beclomethasone and formoterol)
High carbon footprint.
Proxor®(fine-particle beclomethasone and formoterol)
High carbon footprint.
Vivaire®(fine-particle beclomethasone and formoterol)
High carbon footprint.
Symbicort®100/3 (budesonide and formoterol)
Very high carbon footprint.

Triple therapy ICS/LABA/LAMA
Only to be considered in severe COPD which is not controlled by two inhaled drugs  
For patients already on triple therapy using 2 devices (e.g. LAMA plus LABA/ICS) it may be cost effective to prescribe this as a single fixed dose device.

Prescribe by brand, preferred brand is:
Trimbow NEXThaler®DPI (88/5/9) (fine-particle beclometasone, formoterol and glycopyrronium)
Licensed for COPD only.
Trimbow®pMDI (87/5/9) (fine-particle beclometasone, formoterol and glycopyrronium)
Licensed for COPD and Asthma
Trimbow®pMDI (172/5/9) (fine-particle beclometasone, formoterol and glycopyrronium)
Licensed for Asthma only.

Cromoglicate, related therapy and leukotriene antagonists

Leukotriene antagonists
When used in asthma offer a trial of leukotriene receptor antagonist (LTRA) and review the response to treatment in 8 to 12 weeks. 

Montelukast
Licensed from age 6 months

Antihistamines

Available over the counter for hayfever/seasonal allergic rhinitis Over the counter products - when to prescribe

Cetirizine
Loratadine
If liquid required, loratadine more cost-effective than cetirizine
Chlorphenamine

Mucolytics

4 week trial; stop if no benefit seen.
Carbocisteine 375mg capsule
Acetylcysteine sugar free effervescent tablets 600mg preferred if liquid or once daily preparation required 
115mg Na+ per tablet = 1/20th recommended daily intake

Nervous system

Guidance

Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia
Prescribing Guideline for Treatment of Depression in Adults in Primary Care

Hypnotics and Anxiolytics

Insomnia Newer Hypnotic Drugs
NICE TA77 – (April 2004)

  • When, after due consideration of the use of non-pharmacological measures, hypnotic drug therapy is considered appropriate for the management of severe insomnia interfering with normal daily life, it is recommended that hypnotics should be prescribed for short periods of time only, in strict accordance with their licensed indications.
  • It is recommended that, because of the lack of compelling evidence to distinguish between zaleplon, zolpidem, zopiclone or the shorter acting benzodiazepine hypnotics, the drug with the lowest purchase cost (taking into account daily required dose and product price per dose) should be prescribed.
  • It is recommended that switching from one of these hypnotics to another should only occur if a patient experiences adverse effects considered to be directly related to a specific agent. These are the only circumstances in which the drugs with the higher acquisition costs are recommended.
  • Patients who have not responded to one of these hypnotic drugs should not be prescribed any of the others.

Benzodiazepine indications

  • Benzodiazepines are indicated for the short-term relief (two to four weeks only) of anxiety that is severe, disabling, or causing the patient unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic, or psychotic illness.
  • The use of benzodiazepines to treat short-term ‘mild’ anxiety is inappropriate.
  • Benzodiazepines should be used to treat insomnia only when it is severe, disabling or causing the patient extreme distress - BNF

Anxiolytics 
Diazepam
(if liquid formulation required prescribe as Oral Solution SF) 

Hypnotics 
Zaleplon, zolpidem and zopiclone are non-benzodiazepine hypnotics, but they act as the benzodiazepine receptor.  They are not licensed for long-term use; dependence has been reported in a small number of patients.

Antidepressant drugs

Prescribing Guideline for Treatment of Depression in Adults in Primary Care

First prescribe an SSRI in generic form unless there are interactions with other drugs; consider using citalopram or sertraline because they have less propensity for interactions.
When prescribing antidepressants, be aware that:

  • Dosulepin should not be prescribed
  • Non-reversible monoamine oxidase inhibitors (MAOIs; for example, phenelzine), combined antidepressants and lithium augmentation of antidepressants should normally be prescribed only by specialist mental health professionals

Take into account toxicity in overdose when choosing an antidepressant for patients at significant risk of suicide. Be aware that:

  • Compared with other equally effective antidepressants recommended for routine use in primary care, venlafaxine is associated with a greater risk of death from overdose
  • Tricyclic antidepressants (TCAs), except for lofepramine, are associated with the greatest risk in overdose.

When prescribing antidepressants for older people:

  • Prescribe at an age-appropriate dose taking into account the effect of general physical health and concomitant medication on pharmacokinetics and pharmacodynamics
  • Carefully monitor for side effects

Selective serotonin re-uptake inhibitors 
Sertraline
(For patients with co-existing CHD)
Escitalopram
(First line in epilepsy)
Fluoxetine
(First line for <24 years of age) where capsules are unsuitable prescribe as 20mg/5ml oral solution (not SF) or 20mg dispersible tablets

Tricyclic-related antidepressants 
Mirtazapine
(Sedative effect may be beneficial in sleep disturbances)

Other antidepressant drugs 
Third line options after trial of alternative first line option:
Venlafaxine
(monitor BP before and during treatment)
Vortioxetine
(cognitive enhancement independent of depression)
Duloxetine
(if pain a predominant co-morbid symptom)

Drugs used in nausea and vertigo

Dopamine receptor antagonists 
Metoclopramide
Not recommended for patients <20 years

Phenothiazines and related drugs 
Prochlorperazine
Betahistine

Analgesics

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB

Limited amount of evidence that combinations containing low doses of opioid e.g. 8 mg codeine are more effective than aspirin or paracetamol alone. Soluble products not included due to high sodium content.

Non-opioid analgesics and compound analgesic preparations 
Paracetamol tablets  (OTC) 
Co-codamol tablets 8/500 (OTC)

High strength
1st line - Co-codamol tablets 30/500 
2nd line -
Co-codamol capsules 30/500
No longer cheaper to prescribe separately
Codeine phosphate

Opioid analgesics 
Morphine
Prescribe by brand, which must stay consistent
Preferred brand – Zomorph® capsules (twice a day preparation)

Zomorph® capsules can be swallowed whole or opened and sprinkled on food.
Diamorphine
Fentanyl patches (pack of 5 only) preferred brands Matrifen®, Mezolor® and Opiodur® 
Dexamethasone
Midazolam
Cyclizine
Levomepromazine- for a 6.25mg dose, use a 25mg tablet broken into quarters

Antimigraine drugs

Simple Analgesic plus anti-emetic
Several combination products are available

Triptans 
Reserve triptans for patients in whom adequate doses of analgesics and anti-emetics are not effective.  Monitor patients and review if patient overusing as potential for medication overuse headache.
Sumatriptan 50mg
Naratriptan 2.5mg
Rizatriptan 10mg Orodispersible tablets SF

Infections

Guidance

Penicillin allergy de-labelling guideline [pdf] 737KB
Antimicrobial Clinical Topics page
Overview | Amantadine, oseltamivir and zanamivir for the treatment of influenza | Guidance | NICE
NI CE/UKHSA Summary of antimicrobial prescribing guidance - managing common infections

Useful Resources

 NICE/UKHSA Summary of antimicrobial prescribing guidance - managing common infections

See the British National Formulary (BNF) for appropriate use and dosing in specific populations, for example, hepatic impairment, renal impairment, pregnancy and breastfeeding.

Unnecessarily long courses of antimicrobials are one of the factors driving antimicrobial resistance and an increased risk of Clostridioides difficile infection in at-risk populations. Follow national guidance on prescribing the shortest effective course. For example, the NICE/UKHSA summary currently recommends a 5-day course when prescribing for acute sore throat, acute otitis media, sinusitis, acute cough and acute exacerbations of COPD.

Antimicrobial Stewardship resources
TARGET antibiotics toolkit hub 
Discussing antibiotics with patients: Overview 
Leaflets to discuss with patients: How to use these leaflets
Caring for children with coughs leaflet
Learning resources for prescribers: Webinars and webinar recordings 
How to..? Resources (repeat and long term antibiotics)
One-page summary from the University of Bristol ‘Using STARWAVe in practice to predict hospitalisation’: Using the STARWAVe score in clinical practice and recommendations for antibiotic prescribing. 
Antimicrobial stewardship | Topic | NICE - All NICE products on antimicrobial stewardship. Includes guidance, advice and quality standards.
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use | Guidance NG15  | NICE
UK-AWaRe antibiotic classification - GOV.UK

Antimicrobial Stewardship related Tablet Press Extras
Tablet Press Extra - Implementing Back-up (delayed) antibiotic prescribing
Tablet Press Extra - Shorter courses of antibiotics are better!
Tablet Press Extra - Recurrent UTI

Antibacterials

Penicillins
Phenoxymethylpenicillin (Pen V)
Amoxicillin
Flucloxacillin
Co-amoxiclav - only first choice for human & animal bites, uncomplicated diverticulitis, cellulitis and erysipelas near the eyes or nose, sinusitis (only if systemically very unwell or high risk of complications), community acquired pneumonia (only if high severity in adults or severe in children) and hospital acquired pneumonia (non-severe and not higher risk of resistance).
Pivmecillinam 200mg for lower UTI only (second line).

Cephalosporins
Cefalexin

Tetracyclines 
Doxycycline
Lymecycline

Macrolides
Clarithromycin (first choice macrolide)
Erythromycin (preferred for some indications in pregnancy and breast feeding  - see NICE/UKHSA Summary of antimicrobial prescribing guidance - managing common infections)
Azithromycin - Chlamydia treatment option for pregnant women
Vancomycin - see National Institute for Health and Care Excellence (NICE) guidance [NG199] for Clostridioides difficile infection: antimicrobial prescribing
Trimethoprim – nitrofurantoin is preferred for most patients especially where risk of resistance is high e.g. over 70s. Trimethoprim should only be used in over 70s where sensitivity has been confirmed on MSU.
Metronidazole
Ciprofloxacin* only first choice for acute prostatitis (guided by susceptibilities when available). *See the MHRA January 2024 advice on restrictions and precautions for using fluoroquinolone antibiotics because of the risk of disabling and potentially long-lasting or irreversible side effects.
Nitrofurantoin 50mg capsules
Methenamine Hippurate - Prophylaxis of recurrent urinary tract infections.

Antifungal drugs

Fluconazole
Itraconazole
Nystatin oral suspension
Treat fungal nail infections only after confirmed mycology. Topical preparations should be purchased rather than prescribed.
Terbinafine

Herpes virus infections

Aciclovir

Influenza treatment 

Oseltamivir
Zanamivir
NICE technology appraisal (TA168)
Oseltamivir and Zanamivir recommended as possible treatments for people with flu if all of the following apply:

  • The person is in an ‘at risk’ group.
  • The person has a ‘flu-like illness’ and can start treatment within 48 hours (36 hours for Zanamivir treatment in children) of the first sign of symptoms.
  • The Department of Health and Social Care has confirmed that the flu virus is known to be circulating and it is likely that a flu-like illness has been caused by the flu virus.

Endocrine system

To be added.

Genito-urinary system

Guidance

Overactive bladder prescribing pathway
Guidelines for drugs and devices used in the treatment of erectile dysfunction
Overview | Mirabegron for treating symptoms of overactive bladder | Guidance | NICE
Overview | Urinary incontinence and pelvic organ prolapse in women: management | Guidance | NICE
FSRH Clinical Guideline: Emergency Contraception

Urinary frequency, enuresis and incontinence

Antimuscarinics (systemic) - Consider high anticholinergic burden
Solifenacin 5mg-10mg - prefered once a day preparation
Tolterodine immediate-release 1mg - 2mg - prefered twice a day preparation
Fesoterodine MR 4mg - 8mg - prefered modified release preparation

Beta3-Adrenoceptor agonists 
Mirabegron - Option only if antimuscarinic drugs are ineffective, contraindicated or not tolerated. See NICE TA290 and local OAB guidance.

Urinary retention

Alpha-adrenoceptor blockers
Doxazosin tablets (not m/r)
If 8mg required prescribe as 2 x 4mg
Tamsulosin 400mcg m/r capsules

Contraceptives, combined

 
Combined oral contraceptive content Available products. Preferred formulary choices in bold Notes

Ethinylestradiol 30 micrograms and
levonorgestrel 150 micrograms

Levest®
Rigevidon®
Maexeni®
Ovranette®
Microgynon 30®
Microgynon 30 ED®
Progestogen dominant pill

Ethinylestradiol 35 micrograms and
norethisterone 500 micrograms

Brevinor® Oestrogen dominant pill
Ethinylestradiol 30 micrograms and
desogestrel 150 micrograms

Cimizt 30/150®
Gedarel 30/150®
Marvelon®
Consider in mild acne
Note: MHRA advice on risk of VTE

Ethinylestradiol 20 micrograms and
desogestrel 150 micrograms

Bimizza®
Gedarel 20/150®
Mercilon®
Note: MHRA advice on risk of VTE

Ethinylestradiol 30 micrograms and
gestodene 75 micrograms

Millinette 30/75®
Katya 30/75®
Femodene®
Improved cycle control
Note: MHRA advice on risk of VTE

Ethinylestradiol 20 micrograms and
gestodene 75 micrograms

Millinette 20/75®
Sunya®
Akizza®
Femodette®
Note: MHRA advice on risk of VTE

Ethinylestradiol 30 micrograms and
Levonorgestrel 50 micrograms

Ethinylestradiol 40 micrograms and
Levonorgestrel 75 micrograms

Ethinylestradiol 30 micrograms  and
Levonorgestrel 125 micrograms

TriRegol®
Logynon®
Tri-phasic preparation
Improved cycle control but requires better compliance

Ethinylestradiol 35 micrograms and
norgestimate 250 micrograms

Lizinna®
Cilique®
 

Co-cyprindiol 2000/35
(cyproterone acetate 2mg, ethinylestradiol 35 micrograms)

Clairette®
Dianette®
Co-cyprindiol 2000/35
Severe acne, moderately severe hirsuitism.
Should not be prescribed for the sole purpose of contraception. Prescriptions should be endorsed with the female symbol ♀ or CC

The risk of VTE in association with drospirenone-containing pills, including Yasmin, is higher than that for levonorgestrel-containing ‘second generation’ pills and may be similar to the risk for ‘third-generation’ pills that contain desogestrel or gestodene. See full MHRA warning
If Yasmin® equivalent is still needed, please prescribe as Yacella® , or Dretine®  brand (Ethinylestradiol 30 micrograms, Drospirenone 3mg)

Contraceptive, emergency

For choice of product see decision making algorithm in FSRH guideline on Emergency Contraception
Ulipristal acetate 30mg
Available OTC as ellaOne® from all pharmacies
Levonorgestrel 1500 micrograms
Available OTC as Levonelle One Step® from all pharmacies for over-16s.  
Available from many pharmacies under PGD, including for under 16s

Contraception, oral progestogen-only

Desogestrel 75 microgram Prescribe generically
Desogestrel has a 12-hour missed pill window and may be useful where poor compliance is likely.  However, it is only recommended for use in women who cannot tolerate oestrogen-containing contraceptives or in whom these preparations are contraindicated.

Erectile dysfunction

Guidelines for drugs and devices used in the treatment of erectile dysfunction
Sildenafil
“SLS” criteria no longer apply to generic sildenafil.  
Max 8 tablets per month 
Tadalafil 10mg, 20mg PRN (not daily)
“SLS” criteria apply.  
Max 8 tablets per month
Tadalafil 5mg DAILY
2.5mg is double red
“SLS” criteria apply.

Blood and Nutrition

Guidance

BSG Guidelines for the Management of Iron Deficiency Anaemia in Adults

www.healthystart.nhs.uk

See Vitamin D guidelines for formulary preparations Guidelines for the management of Vitamin D deficiency and insufficiency in children, adolescents and adults

Adults- Nutrition and Dietetics

Paediatric- Nutrition and Dietetics

Vitamin D Guidance in Adult and Children

Vitamin D Insufficiency-Patient Leaflet

Anaemias

Iron deficiency anaemia  
Iron (oral): once daily (or alternate day) dosing
Monitor the haematological response and modify as appropriate.
Ferrous sulphate 200mg tablets (65mg elemental iron)
Ferrous fumarate 210mg tablets (69mg elemental iron)
Ferrous fumarate 322mg tablets (106mg elemental iron) High elemental iron content; side effects more likely.
Ferrous gluconate 300mg tablets (37mg elemental iron) Consider using if GI tolerability issues persist even with alternate daily dosing of above preparations.
Ferrous fumarate 140mg/5ml oral solution
BSG Guidelines for the Management of Iron Deficiency Anaemia in Adults

Vitamin Deficiency

Vitamin D 
For the management of insufficiency (serum 25(OH)D 25-50nmol/L) and the routine prophylaxis of deficiency, vitamin D should be purchased OTC or, if eligible, obtained free of charge, or at a reduced cost, via the government’s “Healthy Start” schemewww.healthystart.nhs.uk
This includes prevention of deficiency in pregnant women, including those with high BMI and in other at risk groups. 
For the treatment of deficiency ( serum 25(OH)D <25nmol/L) vitamin D may be provided via NHS prescription.   
See Vitamin D guidelines for formulary preparations Guidelines for the management of Vitamin D deficiency and insufficiency in children, adolescents and adults

Vitamin D with calcium  
Calci D® chewable tablets (once daily dose) (Colecalciferol 1,000unit / Calcium carbonate 2.5g chewable tablets)
Accrete D3® film-coated tablets (swallowed whole or halved) (Colecalciferol 400unit / Calcium carbonate 1.5g tablets)
Evacal D3® chewable tablets (Colecalciferol 400unit / Calcium carbonate 1.5g chewable tablets) If a twice daily chewable tablet is needed

Musculoskeletal system

Non-steroidal Anti-inflammatory Drugs

NICE Guidance: Osteoporosis. Consider topical NSAID if needed and no contra-indications (particularly if hand or knee involvement)
Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB

NPAG does not recommend the use of coxibs. In high GI risk patients where simple analgesics provide inadequate relief then prescribe a traditional NSAID with Lansoprazole 15-30mg daily.

Ibuprofen available OTC
Naproxen
Avoid M/R preparations and E/C versions as they are considerably more expensive without additional benefits. 
Diclofenac

There are now concerns about the cardiovascular safety which appear to have a similar risk to coxibs

Drugs for the Relief of Soft-tissue Inflammation
Fenbid Gel® - only prescribe for long-term conditions as available OTC
(Ibuprofen 5% gel but should prescribe as Fenbid® 100g)

Eye

Guidance

Guidance on the use of eye lubricants for dry eye conditions in primary care [pdf] 205KB

Glaucoma Prescribing Guidelines

Antibacterials

Chloramphenicol 0.5% eye drops 10ml or 1% eye ointment 4g -Available OTC for acute bacterial conjunctivitis in adults and children over 2 years  
Fusidic Acid 1% MR eye drops 5g

Corticosteroids

Corticosteroid eye preparations - should be prescribed on specialist recommendation

Other Anti-inflammatory Preparations

Sodium cromoglicate 2% eye drops 13.5ml - Available OTC (10ml) for acute seasonal and perennial allergic conjunctivitis 
Azelastine 0.05% eye drops 8ml
Antazoline 0.5% with xylometazoline 0.05% eye drops 8ml (Otrivine Antistin®) - Available OTC

Treatment of Glaucoma

Eye preparations for glaucoma should be prescribed on specialist recommendation. 

Miscellaneous Ophthalmic Preparations

Advise self-care where possible and advise patient to purchase preparations OTC Over the counter products - when to prescribe
See ‘Guidance on the Use of Eye Lubricants for Dry Eye Conditions in Primary Care’ (‘Ocular Lubricant Guidelines’) 

Ophthalmic Preparations

 
Standard Formulations

Available OTC

AaproMel® Hypromellose 0.3% or 0.5% eye drops 10ml (hypromellose) one-month expiry
Clinitas® Carbomer 0.2% eye gel 10g (carbomer 980) one-month expiry
Eyeaze® Carmellose 0.5% preservative free eye drops 10ml (carmellose) three-month expiry

Preservative Free Formulations (consider as detailed in Guidelines above)

Available OTC

Eyeaze® Carmellose 0.5% preservative free eye drops 10ml (carmellose) three-month expiry
Hy-Opti® 0.1% 10ml (sodium hyaluronate) six-month expiry
Eyeaze® 0.1% or Eyeaze Lyte® 0.1% (sodium hyaluronate) – three-month expiry
Hy-Opti® 0.2% 10ml (sodium hyaluronate) six-month expiry
Eyeaze® 0.2% or Eyeaze Lyte® 0.2% (sodium hyaluronate) – three-month expiry

High Viscosity Formulations (for use at night in addition to daytime treatment)

Available OTC

Hylo Night® preservative free eye ointment 5g (retinol palmitate with WSP, LLP, LP, and wool fat) six-month expiry
Xailin Night® eye ointment 5g (liquid paraffin with WSP and wool alcohols) two-month expiry

Ear, Nose and Oropharynx

Guidance

Mild to moderate hay fever/seasonal rhinitis is listed by NHS England as a condition where OTC medicines should not routinely be prescribed in primary care. Most patients should be able to relieve symptoms with OTC treatments

See Tablet Press Extra ‘Hay Fever Treatment Update - OTC’ 

Otitis Externa

Over the counter products - when to prescribe
First use aural toilet (if available) and simple analgesia
Acetic Acid 2% ear spray 5ml (Earcalm® spray)
Available OTC
Acetic Acid 2%/Dexamethasone 0.1%/Neomycin 0.5% ear spray 5ml (Otomize® ear spray)
Available OTC

Drugs acting on the Nose

Over the counter products - when to prescribe
Drugs used in nasal allergy

Corticosteroids
Beclometasone 50mcg/dose aqueous nasal spray 200 sprays
Available OTC for adults for prevention and treatment of allergic rhinitis in 100 and 180 spray sizes. 
Budesonide 64mcg/dose nasal spray 120 sprays 
Available OTC for adults for prevention and treatment of seasonal allergic rhinitis in 60 and 120 spray sizes.
Fluticasone furoate 27.5mcg/dose 120 sprays
Available OTC for adults.
Mometasone furoate 50micrograms/dose nasal spray
Indicated for use in adults and children 3 years of age and older to treat the symptoms of seasonal allergic or perennial rhinitis.
Indicated for the treatment of nasal polyps in adults 18 years of age and older.

Topical Nasal Decongestants
Sodium chloride 0.9% nasal drops 10ml

Nasal Preparations for Infection (nasal staphylococci)

Chlorhexidine 0.1% and neomycin 0.5% nasal cream (Naseptin® nasal cream)

Drugs for Oral Ulceration and Inflammation

Over the counter products - when to prescribe
Chlorhexidine gluconate 0.2% mouthwash 300ml(Corsodyl® mouthwash) OTC
Benzydamine 0.15% mouthwash sugar free 300ml (Difflam® rinse) OTC

Oropharyngeal Anti-infective Drugs - Fungal Infections

Miconazole 20mg/g oromucosal gel sugar free 80g (Daktarin® oral gel)
Available OTC in 15g size
Nystatin 100,000 units/ml oral suspension 30ml

Treatment of Dry Mouth (artificial saliva products)

Over the counter products - when to prescribe
Saliveze® mouth spray 50ml (OTC)
Artificial Saliva Gel (Biotene Oralbalance® saliva replacement gel) 50g (OTC)

Skin

Emollient and Barrier Preparations

There is no advantage in prescribing these products by generic name. Choice is largely based on patient preference.

Emollients

There is a risk of severe and fatal burns with ALL emollients. See MHRA/CHM advice (updated May 2021): Emollients: new information about risk of severe and fatal burns with paraffin-containing and paraffin-free emollients. Emollients and risk of severe and fatal burns: new resources available - GOV.UK 

Mild dry skin is listed by NHS England as a condition where OTC medicines should not routinely be prescribed in primary care. Most patients should be able to relieve symptoms with OTC treatments. Emollients can continue to be prescribed for patients with long term dermatological conditions such as eczema and psoriasis. 
Guidance on conditions for which over the counter items should not routinely be prescribed in primary care

‘Epimax’ and ‘Zero’ product ranges provide cost effective equivalents to many commonly used emollients and soap substitutes and are suitable for initial prescribing in most cases. These should be first choice. Patients already established on more expensive products should be encouraged to try the equivalent ‘Epimax’ or ‘Zero’ product. 

See Northamptonshire Emollient Guidelines 

See Northamptonshire OTC When To Prescribe

Emollients for Mild Dry Skin

 
Creams containing paraffin:

Epimax® Moisturising Cream Flexi-dispenser 500g
Zerocream® pump 500g

Creams/lotions containing Colloidal Oatmeal:

Epimax® Oatmeal Cream Flexi-dispenser 500g
Zeroveen® pump 500g

Rich creams for mild dry skin

Zeroguent cream® 500g 

Aveeno preparations are Borderline Substances and have been classed as Double Red. Aveeno preparations are available OTC if patients prefer to purchase them instead of the formulary choices.

Emollients for Moderately Dry Skin

 
Creams containing paraffin:

Epimax® Original Cream Flexi-dispenser 500g
Zerobase® Cream Pump 500g 
Epimax Excetra® Cream Flexi-dispenser 500g 

Gels containing paraffin

Epimax Isomol® Gel Flexi-dispenser 500g
Zerodouble® Gel 

Creams containing urea

ImuDERM® Emollient 5% Urea pump 500g

Emollients for Severe Dry Skin

 
Ointments containing paraffin

Epimax® Ointment 500g
Zeroderm® Ointment 500g

Epimax Ointment can harm the eyes if used on the face. Do not prescribe these  ointments for use on the face. Tell patients to wash their hands and avoid touching their eyes after using these products. See MHRA advice

 
Creams containing Urea 5% and Lauromacrogols 3% Balneum Plus® Cream 500g or 100g – use for itch if emollient alone not helped
 
Sprays containing paraffin

Emollin® Spray 240ml
Use only when unable to use other preparations or where application without touching skin is necessary. Highly flammable.

 
Emollients with Anti-bacterial

Dermol® 500 lotion pump 500ml
Use for washing only when infection is present or recurrent. Avoid regular use.
Use should be targeted and short term. Avoid adding to repeat prescription.
Revert to non-antimicrobial containing emollient once condition is controlled

 
Paraffin Free Emollient

Epimax® Paraffin Free Ointment 500g
Epimax Paraffin-Free Ointment can harm the eyes if used on the face. Do not prescribe these ointments for use on the face. Tell patients to wash their hands and avoid touching their eyes after using these products. See MHRA advice.

 
Soap Substitutes ZeroAQS® (does not contain sodium lauryl sulphate)
Aqueous cream® (contains sodium lauryl sulphate)
Emulsifying ointment®

Bath and Shower Additives 

Bath and shower additives have not been included in this formulary due to lack of evidence of efficacy. 

Any emollient (except white soft paraffin) can be used as a soap substitute. This can be applied prior to washing and directly afterwards onto damp skin. They provide greater moisturising than emollients marketed specifically as bath or shower preparations that don’t have enough contact with the skin. The use of bath emollients/oils and shower products are not routinely recommended for the majority of dermatological conditions as they are less effective than alternatives.

There is an exception where a bath additive may be beneficial to patients and should be made available:

Balneum Plus Bath Oil can be used for managing itch that remains a problem despite optimum topical therapy. Follow the manufacturer’s instructions. 

As per NHSE recommendations prescribers in primary care should not initiate bath and shower preparations for any new patients. However, where clinically advised by a specialist and appropriate, prescribing may continue.

Barrier Creams

See Northamptonshire Dressings Formulary

Topical Corticosteroids

Hydrocortisone preparations
Prices vary considerably between pack sizes; prescribe 1% preparations as multiples of 30g, not 50g.
Hydrocortisone 2.5% is much more expensive than 1% and is ‘Double Red’. Consider clobetasone preparations if hydrocortisone 1% is not effective.

 
Mild potency steroids Hydrocortisone 1% cream/ointment - available OTC
Moderate potency steroids Betametasone 0.025% (Betnovate RD) cream/ointment
Clobetasone butyrate 0.05% (Eumovate) cream/ointment -15g cream available OTC
Potent steroid Betamethasone 0.1% (Betnovate) cream/ointment
Very potent steroid Clobetasol propionate 0.05% (Dermovate) cream/ointment
Mild steroids with anti-fungal Hydrocortisone 1%/miconazole 2% cream/ointment (Daktacort cream/ointment) -15g cream available OTC
Hydrocortisone 1%/clotrimazole1% cream (Canesten HC) -15g available OTC

Preparations for Eczema and Psoriasis

Specialist led
See Management of Psoriasis (Adults & Children) in Primary Care

Drugs affecting the Immune Response

Tacrolimus and pimecrolimus for atopic eczema NICE TA 82 (Last reviewed: 13 July 2015)
Only use when atopic eczema is not controlled by maximal topical corticosteroid treatment. Initiation by Specialist or GP with special interest and experience. 

Acne and Rosacea

For full acne guidance refer to NICE guideline NG198

Managing Acne Vulgaris
12-week course of 1 of the following first-line treatment options: 

Any acne severity
a fixed combination of topical adapalene with topical benzoyl peroxide
a fixed combination of topical tretinoin with topical clindamycin

Mild to moderate acne severity
a fixed combination of topical benzoyl peroxide with topical clindamycin

Moderate to severe acne severity
a fixed combination of topical adapalene with topical benzoyl peroxide, together with either oral lymecycline or oral doxycycline
topical azelaic acid with either oral lymecycline or oral doxycycline

 
Acne severity Treatment option Drug choices
Any Fixed combination of topical adapalene with topical benzoyl peroxide 0.1% adapalene with 2.5% benzoyl peroxide gel (Epiduo)
0.3% adapalene with 2.5% benzoyl peroxide gel (Epiduo®)
Any Fixed combination of topical tretinoin with topical clindamycin 0.025% tretinoin with 1% clindamycin gel (Treclin)
Mild to moderate Fixed combination of topical benzoyl peroxide with topical clindamycin  3% benzoyl peroxide with 1% clindamycin gel (Duac Once Daily)
5% benzoyl peroxide with 1% clindamycin gel (Duac Once Daily)
Moderate to severe Oral antibiotic (in combination with a fixed combination of topical adapalene with topical benzoyl peroxide) Lymecycline 408mg capsule daily
Doxycycline 100mg capsule daily
Moderate to severe Topical azelaic acid (with either oral lymecycline or oral doxycycline) 15% azelaic acid gel (Finacea)
20% azelaic acid cream (Skinoren)

Preparations for Warts and Callouses

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB
Warts and verrucae are listed by NHS England as a condition where OTC medicines should not routinely be prescribed in primary care. Most patients should be able to relieve symptoms with OTC treatments.
Wart and verruca preparations are ‘Double Red’ and should not be prescribed in primary care. They are available to purchase OTC.
Salicylic acid with lactic acid (Salatac gel or Salactol paint)

Shampoos and other preparations for Scalp and Hair Conditions

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB
Dandruff is listed by NHS England as a condition where OTC medicines should not routinely be prescribed in primary care. Most patients should be able to relieve symptoms with OTC treatments.
Coal tar with salicylic acid and sulfur ointment (Cocois ointment)
Ketoconazole 2% shampoo

Antibacterial preparations

Fusidic acid 2% cream (Fucidin cream) - up to 10 days only, to prevent resistance
Metronidazole 0.75% cream or gel (as Rozex brand)
Silver sulfadiazine 1% cream (Flamazine cream) - for infection in burns wounds

Antifungal preparations

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB
Clotrimazole 1% cream
Miconazole 2% cream (Daktarin® cream)

Fungal nail infections
Fungal nail infections are listed by NHS England as a condition where OTC medicines should not routinely be prescribed in primary care. Most patients should be able to relieve symptoms with OTC treatments. link
Fungal nail preparations are ‘Double Red’ drugs and should not be prescribed in Primary Care. They are available to purchase OTC.

Parasiticidal preparations

Available over the counter Over The Counter (OTC) Products - When to prescribe [pdf] 225KB
Dimeticone 4% lotion 
Malathion 0.5% liquid
Permethrin 1% liquid

Skin Cleansers, Antiseptics and Desloughing Agents

Alcohols and Saline
Irripod saline solution 20ml x 25

Oxidisers and Dyes

Potassium permanganate 0.1% solution diluted 1 in 10 to provide a 0.01% solution - see Guidance on the safe use of potassium permanganate soaks